Trilogy Capital Inc. Abbott Laboratories Transaction History
Trilogy Capital Inc.
- $1.87 Billion
- Q1 2025
A detailed history of Trilogy Capital Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Trilogy Capital Inc. holds 2,488 shares of ABT stock, worth $329,908. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,488
Previous 2,604
4.45%
Holding current value
$329,908
Previous $294,000
12.24%
% of portfolio
0.02%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding ABT
# of Institutions
3,503Shares Held
1.35BCall Options Held
10.5MPut Options Held
8.77M-
Vanguard Group Inc Valley Forge, PA170MShares$22.5 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.2 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$9.01 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.17 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $232B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...